Absci Corporation

NasdaqGS ABSI

Absci Corporation Market Capitalization on February 06, 2025: USD 542.12 M

Absci Corporation Market Capitalization is USD 542.12 M on February 06, 2025, a 24.32% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Absci Corporation 52-week high Market Capitalization is USD 662.17 M on April 09, 2024, which is 22.14% above the current Market Capitalization.
Absci Corporation 52-week low Market Capitalization is USD 292.88 M on November 21, 2024, which is -45.97% below the current Market Capitalization.
Absci Corporation average Market Capitalization for the last 52 weeks is USD 439.83 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NasdaqGS: ABSI

Absci Corporation

CEO	Mr. Sean McClain
IPO Date	July 22, 2021
Location	United States
Headquarters	18105 SE Mill Plain Boulevard
Employees	155
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies Fintech

Description

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Key trends

Past 5 years